Retractable Technologies Net Worth 2010-2023 | RVP
Interactive chart of historical net worth (market cap) for Retractable Technologies (RVP) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Retractable Technologies net worth as of April 25, 2024 is $0.03B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.032B | $0.044B |
| Retractable Technologies, Inc. designs, develops, manufactures, and markets innovative patented safety needle devices for the healthcare industry. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $70.359B | 18.83 |
| Becton Dickinson (BDX) | United States | $67.554B | 19.62 |
| West Pharmaceutical Services (WST) | United States | $28.238B | 47.74 |
| Cardinal Health (CAH) | United States | $25.184B | 15.14 |
| Align Technology (ALGN) | United States | $23.613B | 45.61 |
| Cooper (COO) | United States | $17.928B | 27.13 |
| Labcorp (LH) | United States | $17.493B | 14.94 |
| Henry Schein (HSIC) | United States | $9.406B | 16.27 |
| DENTSPLY SIRONA (XRAY) | United States | $6.412B | 16.90 |
| Merit Medical Systems (MMSI) | United States | $4.299B | 24.59 |
| Patterson (PDCO) | United States | $2.346B | 11.24 |
| STAAR Surgical (STAA) | United States | $2.337B | 73.57 |
| CONMED (CNMD) | United States | $2.156B | 19.56 |
| Atrion (ATRI) | United States | $0.747B | 38.46 |
| Lifevantage (LFVN) | United States | $0.079B | 12.85 |
| Pro-Dex (PDEX) | United States | $0.065B | 24.67 |
| Biolase (BIOL) | United States | $0.005B | 0.00 |